WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 非ヌクレオシド系逆転写酵素阻害剤の薬理学 pharmacology of non nucleoside reverse transcriptase inhibitors
2. 未治療HIV感染患者のための抗レトロウイルス療法の選択 selecting antiretroviral regimens for the treatment naive hiv infected patient
3. HIV抗レトロウイルス療法に関する臨床試験：非ヌクレオシド系逆転写酵素阻害剤 clinical trials of hiv antiretroviral therapy non nucleoside reverse transcriptase inhibitors
4. HIV抗レトロウイルス療法の変更 modifying hiv antiretroviral therapy regimens
5. 妊娠時の抗レトロウイルス剤：非ヌクレオシド系逆転写酵素阻害剤 antiretroviral medications in pregnancy non nucleoside reverse transcriptase inhibitors

Hussar DA1, Snell CW.
Journal of the American Pharmacists Association : JAPhA.J Am Pharm Assoc (2003).2012 Jan-Feb;52(1):120-6. doi: 10.1331/JAPhA.2012.12506.
PMID 22257626

Tomillero A1, Moral MA.
Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2010 Dec;32(10):749-73. doi: 10.1358/mf.2010.32.10.1573763.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Thomson Reuters Integrity(SM), the drug discovery and development portal, http://www.thomsonr
PMID 21225012

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

Baert L1, van 't Klooster G, Dries W, François M, Wouters A, Basstanie E, Iterbeke K, Stappers F, Stevens P, Schueller L, Van Remoortere P, Kraus G, Wigerinck P, Rosier J.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V.Eur J Pharm Biopharm.2009 Aug;72(3):502-8. doi: 10.1016/j.ejpb.2009.03.006. Epub 2009 Mar 27.
Long-acting parenteral formulations of antiretrovirals could facilitate maintenance and prophylactic treatment in HIV. Using the poorly water- and oil-soluble non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) as base or hydrochloride (HCl), nanosuspensions were prepared by
PMID 19328850

リンク元	「リルピビリン」
関連記事	「hydrochloride」